Evolution of the Average Target: Phreesia, Inc.

Evolution of the Target Price: Phreesia, Inc.

Changes in Analyst Recommendations: Phreesia, Inc.

3b201b7fb5466b7dbc4ff27c92e.-pguvWzaMVHuBkwCWK47zLOkodqwxUhjz-H3a4MAUfQ.yO1d9ye4VR25YyhTDOd8hoOd24nyrj40rKi4HfB6FMSWoGfTA65VJZZuOw~61f0682d7782d39686561a53edb6f0c3
05-29 Piper Sandler Downgrades Phreesia to Neutral From Overweight, Adjusts PT to $12 From $23 MT
05-28 Truist Adjusts Price Target on Phreesia to $12 From $11, Maintains Hold Rating MT
05-20 Phreesia Shares Fall After Wells Fargo Downgrade MT
05-20 Wells Fargo Downgrades Phreesia to Equalweight From Overweight, Adjusts Price Target to $9 From $15 MT
05-15 Barclays Downgrades Phreesia to Equalweight From Overweight, Adjusts Price Target to $10 From $24 MT
03-31 Top Midday Decliners MT
03-31 JPMorgan Downgrades Phreesia to Neutral From Overweight, Adjusts Price Target to $16 From $24 MT
03-31 Citigroup Downgrades Phreesia to Neutral From Buy, Adjusts Price Target to $10 From $25 MT
03-31 Baird Downgrades Phreesia to Neutral From Outperform, Adjusts Price Target to $10 From $25 MT
03-31 Truist Downgrades Phreesia to Hold From Buy, Cuts Price Target to $11 From $24 MT
03-24 Mizuho Cuts Price Target on Phreesia to $19 From $22, Keeps Outperform Rating MT
12-11 Truist Cuts Price Target on Phreesia to $29 From $36, Keeps Buy Rating MT
11-13 BMO Capital Initiates Coverage on Phreesia With Outperform Rating, $32 Price Target MT
25-09-05 Truist Lifts Price Target on Phreesia to $36 From $35, Keeps Buy Rating MT
25-08-27 Mizuho Initiates Phreesia at Outperform With $36 Price Target MT
25-05-29 Truist Lifts Price Target on Phreesia to $35 From $34, Keeps Buy Rating MT
25-01-08 KeyBanc Raises Price Target on Phreesia to $30 From $28, Keeps Overweight Rating MT
25-01-08 RBC Upgrades Phreesia to Outperform From Sector Perform, Raises Price Target to $32 From $24 MT
24-12-11 Truist Raises Price Target on Phreesia to $34 From $31, Keeps Buy Rating MT
24-09-06 Truist Securities Adjusts Price Target on Phreesia to $31 From $29, Maintains Buy Rating MT
24-07-11 KeyBanc Adjusts Price Target on Phreesia to $25 From $27, Maintains Overweight Rating MT
24-06-03 Truist Securities Adjusts Price Target on Phreesia to $29 From $35, Maintains Buy Rating MT
24-03-21 JMP Securities Raises Price Target on Phreesia to $30 From $28, Maintains Market Outperform Rating MT
24-03-18 Baird Adjusts Price Target on Phreesia to $31 From $30, Maintains Outperform Rating MT
24-03-15 Raymond James Raises Phreesia's Price Target to $30 From $25, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+17.75%
+14.04%
+6.54%
+28.78%
+27.4%
+31.38%
+37.85%
+2.93%
+32.4%
+10.25%
Average +20.93%
Weighted average by Cap. +14.52%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
11.84USD
Average target price
13.94USD
Spread / Average Target
+17.75%
High Price Target
20.00USD
Spread / Highest target
+68.92%
Low Price Target
9.000USD
Spread / Lowest Target
-23.99%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. PHR Stock
  4. Consensus Phreesia, Inc.